当前位置: 首页 > 详情页

Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Dermatology, Beijing Children’ s Hospital, Capital Medical University, National Center for Children’ s Health, Beijing 100045, China. [2]Department of Dermatovenereology, Maanshan people’ s hospital, Maanshan 243000, China.
出处:
ISSN:

关键词: Vascular anomalies Infantile hemangiomas Capillary malformations Adenosine triphosphate Sensitivity assay In vitro

摘要:
Background The term vascular anomalies include various vascular tumors and vascular malformations, among them infantile hemangiomas and capillary malformations are the most well-known associated diseases in early ages. Multiple drugs have been introduced for intervention, but susceptibility test in vitro were scarcely reported. Objective To evaluate the inhibition effect of different drugs by adenosine triphosphate sensitivity assay in vitro before the treatment of infantile hemangiomas and capillary malformations. Methods Specimens were selected from 5 cases of infantile hemangiomas and 11 cases of capillary malformations. Propranolol, rapamycin, sildenafil and itraconazole were tested for their growth inhibition effect by using the adenosine triphosphate sensitivity assay. Results Propranolol demonstrated inhibitory effects on infantile hemangiomas cells. Rapamycin and itraconazole both showed inhibitory effects on infantile hemangiomas cells and capillary malformations cells. Sildenafil has no growth inhibitory effect on infantile hemangiomas cells or capillary malformations cells. Conclusion Adenosine triphosphate sensitivity assay is a sensitive and useful testing method before the management of vascular anomalies, and individualized medication suggestions for the choice of therapeutic drugs were offered based on the testing result and together with a comprehensive evaluation of each infant.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 4 区 医学
小类 | 3 区 儿科
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 儿科
JCR分区:
出版当年[2018]版:
Q2 PEDIATRICS
最新[2023]版:
Q2 PEDIATRICS

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Department of Dermatology, Beijing Children’ s Hospital, Capital Medical University, National Center for Children’ s Health, Beijing 100045, China.
共同第一作者:
通讯作者:
通讯机构: [1]Department of Dermatology, Beijing Children’ s Hospital, Capital Medical University, National Center for Children’ s Health, Beijing 100045, China. [*1]Department of Dermatology, Beijing Children’ s Hospital, Capital Medical University, National Center for Children’ s Health, Beijing, 100045, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院